Amundi’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $470K | Sell |
1,876
-21,460
| -92% | -$5.38M | ﹤0.01% | 1390 |
|
|
2025
Q1 | $5.48M | Buy |
23,336
+3,294
| +16% | +$773K | ﹤0.01% | 934 |
|
|
2024
Q4 | $6.9M | Sell |
20,042
-16,596
| -45% | -$5.72M | ﹤0.01% | 928 |
|
|
2024
Q3 | $12.4M | Sell |
36,638
-8,099
| -18% | -$2.75M | ﹤0.01% | 801 |
|
|
2024
Q2 | $12.1M | Buy |
44,737
+234
| +0.5% | +$63.2K | ﹤0.01% | 796 |
|
|
2024
Q1 | $12.5M | Sell |
44,503
-150,139
| -77% | -$42.2M | 0.01% | 789 |
|
|
2023
Q4 | $61.9M | Buy |
194,642
+111,698
| +135% | +$35.5M | 0.03% | 486 |
|
|
2023
Q3 | $28.6M | Buy |
82,944
+25,525
| +44% | +$8.8M | 0.01% | 635 |
|
|
2023
Q2 | $21.7M | Sell |
57,419
-41,944
| -42% | -$15.8M | 0.01% | 682 |
|
|
2023
Q1 | $46.1M | Sell |
99,363
-152,688
| -61% | -$70.8M | 0.02% | 520 |
|
|
2022
Q4 | $116M | Buy |
252,051
+78,235
| +45% | +$36.1M | 0.06% | 313 |
|
|
2022
Q3 | $79.3M | Buy |
173,816
+145,942
| +524% | +$66.6M | 0.05% | 393 |
|
|
2022
Q2 | $13.6M | Sell |
27,874
-9,063
| -25% | -$4.42M | 0.01% | 706 |
|
|
2022
Q1 | $22M | Buy |
36,937
+1,191
| +3% | +$711K | 0.01% | 634 |
|
|
2021
Q4 | $22.8M | Buy |
35,746
+30
| +0.1% | +$19.2K | 0.01% | 653 |
|
|
2021
Q3 | $26.6M | Buy |
35,716
+763
| +2% | +$569K | 0.02% | 609 |
|
|
2021
Q2 | $22.5M | Buy |
+34,953
| New | +$22.5M | 0.02% | 645 |
|